Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and growth factors regulate the aggressiveness and proliferative activity of keratocystic odontogenic tumors

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Oct;114(4):487-96. doi: 10.1016/j.oooo.2012.06.011.

Abstract

Objective: The objective of this preliminary study was to evaluate the expression of matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and growth factors in keratocystic odontogenic tumors (KOTs).

Study design: The expression of MMPs, TIMPs, growth factors, and the extracellular signal-regulated kinase (ERK) 1/2 signaling pathway were assessed by immunohistochemistry in 15 cases of KOT and 4 cases of calcifying cystic odontogenic tumor (CCOT).

Results: KOT samples expressed significantly higher amounts of MMPs, TIMPs, growth factors, epidermal growth factor receptor (EGFR), and ERK compared with CCOT samples, with the exception of MMP-2 and TIMP-1.

Conclusions: MMP-9, TIMP-2, EGF and transforming growth factor α act together and likely regulate the proliferation and aggressiveness of KOT. ERK-1/2 serves as the transducer of signals generated by these proteins, which signal through the common receptor, EGFR. This process may be related to the increased proliferation and aggressiveness observed in KOT.

MeSH terms

  • ErbB Receptors / metabolism*
  • Humans
  • Immunoenzyme Techniques
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Jaw Neoplasms / metabolism*
  • Jaw Neoplasms / pathology*
  • Matrix Metalloproteinases / metabolism*
  • Odontogenic Cyst, Calcifying / metabolism*
  • Odontogenic Cyst, Calcifying / pathology*
  • Statistics, Nonparametric
  • Tissue Inhibitor of Metalloproteinases / metabolism*

Substances

  • Intercellular Signaling Peptides and Proteins
  • Tissue Inhibitor of Metalloproteinases
  • ErbB Receptors
  • Matrix Metalloproteinases